Navigate the Sarepta Therapeutics $SRPT and eteplirsen information pages
Formerly AVI BioPharma $AVII
Introduction
Webcasts and Events
Stock Analysis and Reporting
Eteplirsen Info
Media Reports and Patient Testimonials
Scientific and Medical Presentations
DMD and Competition
Infectious Disease Pipeline
Get first-hand perspective and education information from an inspiring family with two boys with DMD, plus learn how you can make a difference - visit www.DMDHero.com
Introduction
Webcasts and Events
Stock Analysis and Reporting
Eteplirsen Info
Media Reports and Patient Testimonials
Scientific and Medical Presentations
DMD and Competition
Infectious Disease Pipeline
Get first-hand perspective and education information from an inspiring family with two boys with DMD, plus learn how you can make a difference - visit www.DMDHero.com
Data overview from September 2012
The slide deck embedded below gives an overview of the data presented in the past year or so. See the links below for more complete information on the individual scientific publications and medical conference presentations.
April 2012 - American Academy of Neurology
Dr. Jerry Mendell presented phase 2 data from the SRPT eteplirsen clinical trial in Duchenne Muscular Dystrophy (DMD) at the AAN meeting in New Orleans. Click here for additional details and to view the poster and slide show presentations.
April 2011 - American Academy of Neurology
Check out the summary article from AAN featuring presentations on PRO051, ataluren, and AVI-4658 (eteplirsen)